Favorites chosen by Cleveland Clinic’s Radiation Oncology staff at the 2015 American Society for Radiology Oncology (ASTRO) annual meeting.
Lung tumors bearing the BRAF mutation are resistant to radiation therapy, but a new study finds they can be sensitized to it by commercially available MEK inhibitors. This could benefit 4-6 percent of patients with lung cancer.
Early salvage radiotherapy after prostatectomy found to be associated with improved freedom from biochemical failure and distant metastases. Updated nomogram more accurately predicts patient outcomes.
Researchers at Cleveland Clinic develop a way to predict distant metastases in patients with early-stage lung cancer after stereotactic body radiotherapy using readily available patient variables.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Radiotherapy for head and neck cancer is associated with significant morbidity. A Cleveland Clinic study highlights the important role APNs can play in reducing adverse events after treatment with better follow-up care.
Potentially good news for the 170,000+ people in the U.S. diagnosed each year with melanoma brain metastases. Study finds better outcomes when combining stereotactic radiosurgery with tumor molecular analysis.
Cleveland Clinic’s QMAP software for radiation oncology improves treatment quality, patient safety and efficiency by alerting clinicians of deviations from local standard of timeliness for planning and delivery of therapy.